ceo-two bowel evacuant suppositories suppositoire
beutlich l.p. - bicarbonate de sodium; bitartrate de potassium - suppositoire - 627mg; 942mg - bicarbonate de sodium 627mg; bitartrate de potassium 942mg - cathartics and laxatives
blincyto
amgen europe b.v. - blinatumomab - cellule précurseur leucémie lymphoblastique - lymphome - agents antinéoplasiques - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
hibitane 5 pour cent, solution pour application locale à diluer
regent medical overseas limited - chlorhexidine (gluconate de) - solution - 5,00 g - composition pour 100 ml > chlorhexidine (gluconate de) : 5,00 g - antiseptiques et desinfectants
aminosyn ii solution
icu medical canada inc - l-isoleucine; l-leucine; l-lysine (acétate de l-lysine); méhionine; l-phénylalanine; l-thréonine; tryptophane; l-valine; l-alanine; l-arginine; acide l-aspartique; acide glutamique; glycine; histidine; l-proline; sérine; n-acétyl-l-tyrosine - solution - 660mg; 1000mg; 1050mg; 172mg; 298mg; 400mg; 200mg; 500mg; 993mg; 1018mg; 700mg; 738mg; 500mg; 300mg; 722mg; 530mg; 270mg - l-isoleucine 660mg; l-leucine 1000mg; l-lysine (acétate de l-lysine) 1050mg; méhionine 172mg; l-phénylalanine 298mg; l-thréonine 400mg; tryptophane 200mg; l-valine 500mg; l-alanine 993mg; l-arginine 1018mg; acide l-aspartique 700mg; acide glutamique 738mg; glycine 500mg; histidine 300mg; l-proline 722mg; sérine 530mg; n-acétyl-l-tyrosine 270mg - caloric agents
aminosyn ii solution
icu medical canada inc - l-thréonine; tryptophane; l-valine; l-lysine (acétate de lysine); méhionine; l-phénylalanine; l-alanine; l-arginine; acide l-aspartique; acide glutamique; glycine; histidine; l-proline; sérine; n-acétyl-l-tyrosine; l-isoleucine; l-leucine - solution - 600mg; 300mg; 750mg; 1575mg; 258mg; 447mg; 1490mg; 1527mg; 1050mg; 1107mg; 750mg; 450mg; 1083mg; 795mg; 405mg; 990mg; 1500mg - l-thréonine 600mg; tryptophane 300mg; l-valine 750mg; l-lysine (acétate de lysine) 1575mg; méhionine 258mg; l-phénylalanine 447mg; l-alanine 1490mg; l-arginine 1527mg; acide l-aspartique 1050mg; acide glutamique 1107mg; glycine 750mg; histidine 450mg; l-proline 1083mg; sérine 795mg; n-acétyl-l-tyrosine 405mg; l-isoleucine 990mg; l-leucine 1500mg - caloric agents
hibisprint, solution pour application locale
regent medical overseas limited - chlorhexidine (digluconate de) - solution - 0,5 g - composition pour 100 ml > chlorhexidine (digluconate de) : 0,5 g > isopropylique (alcool) : 60 g - antiseptique et desinfectant
lincocin solution
pfizer canada ulc - lincomycine (chlorhydrate de lincomycine) - solution - 300mg - lincomycine (chlorhydrate de lincomycine) 300mg - lincomycins
lincocin capsule
pfizer canada ulc - lincomycine (chlorhydrate de lincomycine) - capsule - 500mg - lincomycine (chlorhydrate de lincomycine) 500mg - lincomycins